Surgical · Spine

20250

Open surgical biopsy of a thoracic vertebral body, requiring an incision to directly access and remove bone tissue for pathological analysis.

Verified May 8, 2026 · 5 sources ↓

Medicare
$387.45
Total RVUs
11.6
Global, days
10
Region
Spine
Drawn from CMSAAPCFastrvuFindacode

Documentation requirements

What must appear in the operative or office note to support the claim.

Source · Editorial brief grounded in 5 cited references ↓

  • Specific thoracic vertebral level biopsied (e.g., T6, T8) documented in the operative note
  • Surgical approach described by name — not 'standard approach'
  • Clinical rationale for open rather than percutaneous biopsy (e.g., prior needle biopsy failure, need for larger sample, vascular anatomy)
  • Specimen handling and disposition to pathology documented, including laterality or level labeling
  • Supporting diagnosis with ICD-10 code reflecting the indication (suspected malignancy, osteomyelitis, metabolic bone disease)
  • Anesthesia type and patient positioning documented in the operative report

Applicable modifiers

Modifiers commonly billed with this code.

Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual

What this code covers

Source · Editorial summary grounded in 5 cited references ↓

CPT 20250 covers an open biopsy of the thoracic vertebral body — a surgeon makes a direct incision, exposes the vertebra, and excises a bone tissue sample for laboratory examination. The open approach is chosen when percutaneous needle biopsy (20225) is insufficient, has failed, or when the clinical picture demands a larger, more representative specimen. Indications include suspected primary bone malignancy, metastatic disease, or spinal osteomyelitis where tissue diagnosis will drive treatment.

This is a facility-based procedure performed under general anesthesia. Neurosurgery and orthopedic surgery are the dominant billing specialties. The global period is 10 days — shorter than major spinal procedures but still enough to bundle routine immediate post-op follow-up. CMS NCCI policy is explicit: if a percutaneous needle biopsy (20225) is attempted first at the same encounter and fails, only 20250 is reportable. Do not bill both.

Document the vertebral level, the surgical approach, the reason the open method was selected over percutaneous technique, and the intraoperative specimen disposition. Payers will deny without a supporting diagnosis — malignancy, infection, or metabolic bone disease codes must accompany the claim.

RVU & reimbursement

Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.

Source · CMS Physician Fee Schedule, RVU26A · January 2026

Work RVU5.06
Practice expense RVU5.08
Malpractice RVU1.46
Total RVU11.6
Medicare national rate$387.45
Global period10 days

Payment by site of service

Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.

Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026

SettingMedicare rate (national)
Office (PFS non-facility)
Procedure performed in physician's office
$387.45
HOPD (APC 5113)
Hospital outpatient department
$3,342.87
ASC (PI G2)
Ambulatory surgical center (freestanding)
$1,644.87

Common denial reasons

The recurring reasons claims for CPT 20250 get rejected.

Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓

  • Missing or non-specific ICD-10 diagnosis — payers require a definitive indication such as suspected neoplasm or spinal infection, not just 'back pain'
  • CPT 20225 billed same-day: NCCI bundles the percutaneous needle biopsy into 20250 when both are attempted at the same encounter
  • Insufficient documentation of the open approach — notes lacking incision description or access method trigger medical necessity denials
  • Place of service mismatch — this procedure requires a facility setting; billing with a non-facility POS will trigger payment discrepancies
  • Global period overlap — billing a related E/M or minor procedure within the 10-day global without modifier 24 or 78

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01What's the difference between 20250 and 20225 for a thoracic vertebral biopsy?
20225 is a percutaneous deep bone biopsy by needle or trocar — minimally invasive, no formal incision. 20250 requires an open surgical incision to directly access the vertebral body. If you attempt 20225 first and it fails, convert to 20250 at the same encounter and bill only 20250. CMS NCCI prohibits billing both.
02Is there a lumbar equivalent code for open vertebral body biopsy?
Yes — CPT 20251 covers open biopsy of the vertebral body in the cervical or lumbar region. Use 20250 exclusively for thoracic-level open biopsies. Mixing the two codes or using the wrong one based on the operative note is a common audit finding.
03Can 20250 be billed with a spinal fusion or decompression on the same day?
It depends. If the biopsy is incidental to a larger spinal procedure, payers may bundle it. If it's clinically distinct — different vertebral level or a separate diagnostic indication — append modifier 59 with solid documentation of why it was a separate service. Review NCCI edits for the specific code pairing before billing.
04What modifiers apply when 20250 is performed during the global period of another spinal procedure?
Use modifier 78 if the open biopsy is a related, unplanned return to the OR during the global period of the prior surgery. Use modifier 79 if the biopsy is for a completely unrelated condition. Never invert these — 78 is related, 79 is unrelated.
05Does 20250 require assistant surgeon billing, and which modifier applies?
Open thoracic vertebral biopsy frequently involves an assistant surgeon given the exposure required. Bill the assistant with modifier 80. If a PA or NP assists, use modifier AS instead. Confirm the payer allows assistant surgeon billing for this code — some commercial payers restrict it.
06What ICD-10 codes typically support medical necessity for 20250?
Common supporting diagnoses include vertebral malignancy (primary or metastatic), spinal osteomyelitis, discitis, or unspecified bone lesion requiring histologic confirmation. A diagnosis of nonspecific back pain alone will not support medical necessity and is a frequent denial trigger. The diagnosis should reflect why tissue diagnosis is required.

Mira AI Scribe

Mira's AI scribe captures the thoracic vertebral level, surgical approach, rationale for open versus percutaneous technique, and specimen disposition directly from dictation. That eliminates the most common audit flag on 20250 — operative notes that omit the access method or fail to justify why needle biopsy wasn't used — and ensures the claim ships with the diagnosis and procedural detail payers require on first pass.

See how Mira captures CPT 20250 documentation

Related CPT codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free